CO2022009781A2 - Composición de gel binario nanoestructurado y su uso - Google Patents

Composición de gel binario nanoestructurado y su uso

Info

Publication number
CO2022009781A2
CO2022009781A2 CONC2022/0009781A CO2022009781A CO2022009781A2 CO 2022009781 A2 CO2022009781 A2 CO 2022009781A2 CO 2022009781 A CO2022009781 A CO 2022009781A CO 2022009781 A2 CO2022009781 A2 CO 2022009781A2
Authority
CO
Colombia
Prior art keywords
composition
polymer
nanostructured
relates
gel composition
Prior art date
Application number
CONC2022/0009781A
Other languages
English (en)
Inventor
Esparza Herrera Guillermo U Ruiz
Kanny Chang
Ketian Zhang
Samson Afewerki
Original Assignee
Veri Nano Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veri Nano Inc filed Critical Veri Nano Inc
Publication of CO2022009781A2 publication Critical patent/CO2022009781A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A61K38/385—Serum albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0095—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Materials Engineering (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Dermatology (AREA)
  • Composite Materials (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una composición que comprende una pluralidad de nanopartículas de silicato; un polímero hidrófilo; y agua, y que opcionalmente comprende además un polímero espesante; una pluralidad de partículas de óxido de zinc; un polímero que comprende una pluralidad de grupos funcionales de amonio cuaternario; un polímero adhesivo; un aceite o un poliol. La invención también se refiere al uso de la composición en la prevención y/o el tratamiento de una enfermedad en un mamífero, tal como una enfermedad de la piel o mastitis. La invención se refiere además a un sellador de un conducto en el cuerpo de un mamífero que comprende dicha composición.
CONC2022/0009781A 2019-12-20 2022-07-12 Composición de gel binario nanoestructurado y su uso CO2022009781A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962951982P 2019-12-20 2019-12-20
PCT/US2020/065994 WO2021127423A1 (en) 2019-12-20 2020-12-18 Nanostructured binary gel composition and use thereof

Publications (1)

Publication Number Publication Date
CO2022009781A2 true CO2022009781A2 (es) 2022-07-19

Family

ID=76477983

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2022/0009781A CO2022009781A2 (es) 2019-12-20 2022-07-12 Composición de gel binario nanoestructurado y su uso

Country Status (12)

Country Link
US (1) US20230021329A1 (es)
EP (1) EP4072998A4 (es)
JP (1) JP2023507765A (es)
CN (1) CN115003626A (es)
AR (1) AR120831A1 (es)
AU (1) AU2020405124A1 (es)
BR (1) BR112022011967A2 (es)
CA (1) CA3165385A1 (es)
CO (1) CO2022009781A2 (es)
MX (1) MX2022007584A (es)
UY (1) UY38997A (es)
WO (1) WO2021127423A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO2019012045A1 (es) * 2019-10-29 2021-04-30 Biologicos Estrategicos Bioest S A S Formulación agroquímica antifúngica verde basada en nanomateriales de silicio y zinc

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050191270A1 (en) * 2004-02-27 2005-09-01 Hydromer, Inc. Anti-infectious hydrogel compositions
CA2657829A1 (en) * 2006-08-11 2008-05-29 Panacea Biotec Limited Particles for delivery of active ingredients, process of making and compositions thereof
US8367117B2 (en) * 2010-05-10 2013-02-05 The Research Foundation Of State University Of New York Nanocomposite hyaluronic acid-clay based hydrogels
CA2703807C (en) * 2010-05-12 2017-10-24 Molly S. Shoichet Enhanced stability of inverse thermal gelling composite hydrogels
WO2014153293A1 (en) * 2013-03-18 2014-09-25 Aqua Access Llc Methods and apparatuses related to treatment in milking facilities
SG2013002687A (en) * 2013-04-10 2014-11-27 Areteon Pte Ltd Anti-microbial composition
US9757387B2 (en) * 2013-05-02 2017-09-12 Medical Technology Research Inc Antimicrobial compositions and methods of making the same
WO2014205261A1 (en) * 2013-06-19 2014-12-24 The Brigham And Women's Hospital, Inc. Nanocomposite hydrogels
GB201402672D0 (en) * 2014-02-14 2014-04-02 Medical Res Council Materials and methods relating to stabilised polymeric silicate compositions
US11090354B2 (en) * 2015-08-06 2021-08-17 The Johns Hopkins University Composition and method for treatment of metabolic disorders
PT3370698T (pt) * 2015-11-03 2022-03-02 Zoetis Services Llc Compósitos de polímero sol-gel e utilizações dos mesmos
WO2017223261A2 (en) * 2016-06-23 2017-12-28 3M Innovative Properties Company Hydrogels, articles comprising hydrogels, and methods thereof
WO2018169965A1 (en) * 2017-03-13 2018-09-20 The Texas A&M University System Nanocomposite ionic-covalent entanglement reinforcement mechanism and hydrogel
JP7123971B2 (ja) * 2017-04-20 2022-08-23 ゾエティス・サービシーズ・エルエルシー 乳腺炎を処置する際に使用する動物用組成物、及び関連方法

Also Published As

Publication number Publication date
JP2023507765A (ja) 2023-02-27
AR120831A1 (es) 2022-03-23
AU2020405124A1 (en) 2022-08-04
CN115003626A (zh) 2022-09-02
BR112022011967A2 (pt) 2022-09-06
EP4072998A1 (en) 2022-10-19
EP4072998A4 (en) 2024-01-31
MX2022007584A (es) 2022-10-07
US20230021329A1 (en) 2023-01-26
CA3165385A1 (en) 2021-06-24
WO2021127423A1 (en) 2021-06-24
UY38997A (es) 2021-07-30

Similar Documents

Publication Publication Date Title
CO2018003131A2 (es) Composiciones para el cuidado bucal que comprenden un aminoácido básico, una combinación de fuentes de iones de zinc y un sistema espesante
MX2017004091A (es) Composicion y equipos para inhibicion de infeccion microbiana patogena y metodos para usar los mismos.
AR081450A1 (es) Tratamiento de sarcoidosis usando celulas madre de placenta
CL2008001756A1 (es) Agente de arn de interferencia (iarn); composicion farmaceutica que lo comprende; y su uso para tratar procesos patologicos mediados al menos en parte por la expresion del canal de sodio epitelial alfa (alfa-enac)
CO2022009781A2 (es) Composición de gel binario nanoestructurado y su uso
MX352822B (es) Composiciones biocidas y métodos para utilizar las mismas.
BR112012006756A2 (pt) revestimentos para aplicação na superfície da pele
GB201020193D0 (en) Glucan compositions
BR112014019623A8 (pt) Composição aditiva de condicionamento para o fornecimento benefícios de longa duração e imediatos para substratos de queratina
WO2016113550A3 (en) Dressing
BR112015023648A2 (pt) revestimento de superfície reativo com propriedades de descontaminação química e biocidas
AR071738A1 (es) Metodo para mejorar la apariencia de la piel usando particulas macroscopicas tratadas
CR9351A (es) Composiciones y metodos para aplicaicon topica y suministro transdermico de toxina botulinica
BR112014014832A2 (pt) formulação e método de controlar fungos
BR112017010720A2 (pt) gel aquoso ou alcoólico aquoso de filossilicatos sintéticos como agente de viscosidade, de efeito matificante e/ou agente homogeneizador de aplicação
AR085402A1 (es) No tejido y metodo de produccion del mismo
BR112015005339A2 (pt) composições farmacêuticas tópicas ou cosméticas, método para tratar, prevenir ou melhorar uma condição ou transtorno que afeta a pele, membranas mucosas, cabelo, ou unhas de um animal, composição de auxílio sexual, método para tratar uma condição de transtorno de um animal causada por ou associada a inflamação, métodos para tratar uma articulação de um animal, métodos para melhorar o desempenho de uma articulação de um animal, composições elastoméricas gelatinosas, artigos molgados e artigos flexíveis
BR112016003381A8 (pt) sistema para administrar uma formulação de cantaridina a um indivíduo; dispositivo aplicador para administrar uma formulação de cantaridina a um indivíduo; usos de uma formulação de cantaridina; kit para administrar uma formulação de cantaridina a um indivíduo; formulações; e formulação de cantaridina
GB2564260A (en) Sun protective compositions
BR112015010392A2 (pt) composição para tratamento de pele
CL2012003266A1 (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas; composicion farmacéutica y/o dermocosmética antimicrobiana que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo ; metodo para tratar y/o prevenir a un paciente que tiene una infeccion microbiana.
CO6561814A2 (es) Tira dental para la administracion de tratamiento por la via oral
CL2011002160A1 (es) Compuestos derivados de 3-amino-2-mercaptoquinolinas sustituidas; composicion farmaceutica que contiene dichos compuestos; y su uso para tratar dolor, epilepsis, incontinencia urinaria, manias, migraña, trastornos bipolares, enfermedades cognitivas, discinesia asociada a la distonia y/o incontinencia urinaria.
AR082155A1 (es) Formulacion antiseptica y desinfectante que tiene contenido de yodo reducido
BR112019002287A2 (pt) glicosaminoglicanos reticulados, método para reticulação de um primeiro glicosaminoglicano enxertado com uma fração funcional diol tendo uma porção diol e um segundo glicosaminoglicano enxertado com um hemiéster boronato, uso de um hemiéster boronato, e, composição de polímero.